Skip to main content
Medtronic plc logo

Medtronic plc — Investor Relations & Filings

Ticker · MDT ISIN · US58446C1036 LEI · D56MRZY2INAN94ZONZ37 US Manufacturing
Open in API
Filings indexed 1,143 across all filing types
Latest filing 2020-10-06 Board/Management Inform…
Country US United States of America
Listing US MDT

About Medtronic plc

https://www.medtronic.com/

Medtronic plc is a global healthcare technology company that develops, manufactures, and sells device-based medical therapies and solutions. The company's portfolio addresses more than 70 health conditions, primarily organized into four key areas: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its products range from pacemakers and neurovascular care devices to insulin pumps and systems for robotic-assisted surgery. Medtronic's technologies are designed to be used by healthcare systems, physicians, clinicians, and patients to alleviate pain, restore health, and extend life.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The key content is about the departure of a director and changes in the board of directors, including the retirement of the Executive Chairman and appointment of a new Chairman. The document is focused on management changes and does not contain financial statements or detailed financial data. Therefore, it fits the category of Board/Management Information (MANG). The document length is 5534 characters, which is sufficient to contain substantive information about management changes rather than a brief announcement. Hence, the classification is MANG with high confidence.
2020-10-06 English
NYSE CERTIFICATION
Regulatory Filings Classification · 90% confidence The provided document text appears to be heavily encoded or corrupted, containing mostly non-readable characters and no discernible content related to any specific financial report or announcement. There are no clear references to regulatory bodies, report titles, fiscal periods, or keywords that would indicate a specific filing type. The document length is 15,000 characters, which is substantial, but the content is not interpretable as a financial or corporate filing. Given the lack of meaningful content and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS).
2020-09-30 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It details the registration of various senior notes by Medtronic entities, including descriptions of the securities and references to prospectus supplements and base prospectuses. The document is primarily a regulatory filing to register securities and does not contain financial statements, earnings data, or management discussion. It is not an annual report, earnings release, or capital update but a formal registration statement. Therefore, it fits best under Regulatory Filings (RNS). The document length (6276 characters) and content confirm it is not a brief announcement or a full financial report but a regulatory filing form.
2020-09-29 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content details the issuance of multiple series of senior notes (debt securities) by Medtronic Luxco, including terms, maturity dates, interest rates, and use of proceeds. It also includes information about the underwriting agreement and related legal opinions. The document is focused on a financing transaction involving debt issuance and redemption of existing notes. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, management report, or governance information. The primary subject is the issuance of new debt securities and related financing activities. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the financing event, not just an announcement of a report, so it is not RPA or RNS. Confidence is high given the clear focus on debt issuance and financing terms.
2020-09-29 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus supplement and prospectus related to a debt securities offering by Medtronic Global Holdings S.C.A. It includes registration fee calculations, terms of senior notes due in various years, underwriting details, risk factors, use of proceeds, and legal matters. The document is filed pursuant to Rule 424(b)(5) under the Securities Act of 1933, which is a common filing for securities offerings. The content focuses on the issuance of senior notes (debt securities), their terms, pricing, and underwriting arrangements. This type of document is a capital markets financing disclosure, specifically a prospectus supplement for a debt offering. It is not an annual or interim report, earnings release, management discussion, or any other category. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual offering document, not just an announcement or a brief summary.
2020-09-26 English
PRIMARY DOCUMENT
Director's Dealing
2020-09-25 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.